Adam J. Townsend - 21 Apr 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Commercial Officer
Signature
/s/ David Watson, attorney-in-fact for Adam Townsend
Issuer symbol
APLS
Transactions as of
21 Apr 2022
Net transactions value
-$166,650
Form type
4
Filing time
12 Jul 2022, 17:55:04 UTC
Previous filing
14 Feb 2022
Next filing
04 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Other $0 -1,875 -4.3% $0.000000 42,138 21 Apr 2022 Direct F1
transaction APLS Common Stock Options Exercise $75,450 +5,000 +12% $15.09 47,907 11 Jul 2022 Direct F2
transaction APLS Common Stock Sale $242,100 -5,000 -10% $48.42 42,907 11 Jul 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Other $0 -11,250 -100% $0.000000* 0 21 Apr 2022 Common Stock 11,250 $44.90 Direct F3
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -5,000 -1.3% $0.000000 370,000 11 Jul 2022 Common Stock 5,000 $15.09 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents the cancellation of a PSU awards granted on 01/28/2021 that was originally reported in table I upon grant. The performance metrics were not met.
F2 This is a scheduled exercise and sale form an established 10b5-1 plan.
F3 This represents the cancellation of a performance stock option granted on 01/28/01. The performance metrics were not met.
F4 This represents a stock option granted 11/16/2018 that vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.